Article Versions Notes

Ho C-B, Tsai J-T, Chen C-Y, Shiah H-S, Chen H-Y, Ting L-L, Kuo C-C, Lai I-C, Lai H-Y, Chung C-L, et al. Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression. Diagnostics. 2023; 13(9):1597. https://doi.org/10.3390/diagnostics13091597

Ho, Chin-Beng, Jo-Ting Tsai, Chun-You Chen, Her-Shyong Shiah, Hsuan-Yu Chen, Lai-Lei Ting, Chia-Chun Kuo, I-Chun Lai, Hsin-Yi Lai, Chi-Li Chung, and et al. 2023. "Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression" Diagnostics 13, no. 9: 1597. https://doi.org/10.3390/diagnostics13091597

Ho, C.-B., Tsai, J.-T., Chen, C.-Y., Shiah, H.-S., Chen, H.-Y., Ting, L.-L., Kuo, C.-C., Lai, I.-C., Lai, H.-Y., Chung, C.-L., Lee, K.-L., Tzeng, H.-E., Lee, K.-H., Lee, H.-L., Chen, S.-W., & Chiou, J.-F. (2023). Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression. Diagnostics, 13(9), 1597. https://doi.org/10.3390/diagnostics13091597